Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Antithrombotic Trialists’ Collaboration

Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies
K. Wilson and others

Secondary prevention of coronary heart disease in the elderly
C. J. Bulpitt

Beta blockade during and after myocardial infarction: an overview of the randomized trials
S. Yusuf and others

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
S. Yusuf and others

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double blind, placebo-controlled, multicentre trial (the EUROPA study)
K. Fox and EUROPA Investigators

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Scandinavian Simvastatin Survival Study Group

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
F. M. Sacks and others

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
Heart Protection Study Collaborative Group

An overview of randomized trials of rehabilitation with exercise after myocardial infarction
G. T. O’Connor and others